By strengthening oversight of imported APIs and cracking down on illegal drugs entering the U.S., we are taking aggressive action to protect consumers from poor-quality or dangerous GLP-1 drugs. The FDA has previously warned of serious risks linked to unapproved versions of these drugs, including incorrect dosing, use of unapproved ingredients and adverse health events some requiring hospitalization
GLP-1RAs therefore function as a dual-action therapy by improving metabolic risk factors such as type 2 diabetes and hyperglycaemia and directly protecting the cardiovascular system
MNT spoke with Hsinlin Thomas Cheng, MD, PhD, senior neurologist in the Department of Neurology at Massachusetts General Hospital and assistant professor at Harvard Medical School, about this study
If injectable tirzepatide costs $400/month and produces 2% body weight loss per month, that is $200 per percentage point lost
GLP3+ Cagrilintide Blend is intended for laboratory research use only
Be The First To See Results And Updates Subscribe For a Newsletter Get clinical insights, expert guidance, and real transformation stories straight to your inbox